Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05340309 |
|---|---|
| Brief Title: | Subcutaneous Atezolizumab for the Treatment of Non-small Cell Lung Cancer |
| First Submitted : | April 11, 2022 |
| First Submitted that Met QC Criteria : | April 18, 2022 |
| First Posted : | April 22, 2022 |
| Last Update Submitted that Met QC Criteria : | February 9, 2024 |
| Last Update Posted : | February 13, 2024 |